Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
European Health Economics (EHE) is a specialized health economics and outcomes research (HEOR) consultancy with a prominent reputation in the European life sciences sector. Founded by distinguished health economists including Bengt Jönsson and Gisela Kobelt, the firm provides expert services in economic modeling, cost-of-illness studies, and market access strategy for pharmaceutical and biotechnology companies. EHE is particularly well-known for its extensive research and high-impact publications in therapeutic areas such as neuroscience, oncology, and inflammatory diseases. Although the original business was acquired by UnitedHealth Group (Optum) in 2007 and its core teams later became part of Mapi Group and ICON, the entity remains active through its founders' continued high-level strategic consulting and academic collaborations. The firm is highly regarded for its technical rigor and its role in shaping health technology assessment (HTA) methodologies across Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on European Health Economics.